2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery
- 1 September 2015
- Vol. 66 (12) , 1327-1334
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
- Boston Scientific Corporation
This publication has 24 references indexed in Scilit:
- 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trialThe Lancet, 2015
- Late Cardiac Death in Patients Undergoing Transcatheter Aortic Valve ReplacementJACC, 2015
- Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard TherapyCirculation, 2014
- Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at Extreme Risk for SurgeryJACC, 2014
- The Impact of Frailty Status on Survival After Transcatheter Aortic Valve Replacement in Older Adults With Severe Aortic StenosisJACC: Cardiovascular Interventions, 2012
- 2-Year Results of CoreValve Implantation Through the Subclavian AccessJACC, 2012
- Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic StenosisNew England Journal of Medicine, 2012
- 2-Year Follow-Up of Patients Undergoing Transcatheter Aortic Valve Implantation Using a Self-Expanding Valve ProsthesisJACC, 2011
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010
- The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 2—Isolated Valve SurgeryThe Annals of Thoracic Surgery, 2009